Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hantavirus.

Jan P Clement1

  • 1Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology, Rega Institute and Leuven University Hospitals, Kapucijnenvoer 33, BE-3000 Leuven, Belgium. jan.clement@uz.kuleuven.ac.be

Antiviral Research
|March 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is Skilled Nursing Facility Financial Status Related to Readmission Rate Improvement?

Journal of healthcare management / American College of Healthcare Executives·2022
Same author

Hospital Performance in the First 6 Years of Medicare's Value-Based Purchasing Program.

Medical care research and review : MCRR·2020
Same author

Urban-Rural Differences in Skilled Nursing Facility Rehospitalization Rates.

Journal of the American Medical Directors Association·2018
Same author

Does Assisted Living Capacity Influence Case Mix at Nursing Homes?

Gerontology & geriatric medicine·2017
Same author

The experiences of Massachusetts hospitals as statewide health insurance reform was implemented.

Journal of health care for the poor and underserved·2014
Same author

Hospital philanthropy.

Journal of health care finance·2013
Same journal

The anti-respiratory syncytial virus activity of biochemicals from Pyrola incarnata.

Antiviral research·2026
Same journal

Ginsenoside Rb2-based inactivation enables a Zika vaccine that maintains pregnancy and protects offspring against virus.

Antiviral research·2026
Same journal

ITGA4 drives pathogenesis of flavivirus and inhibition of it protects mice against Japanese encephalitis virus infection.

Antiviral research·2026
Same journal

Corrigendum to "A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2" [Antivir. Res. 225 (2024) 105854].

Antiviral research·2026
Same journal

Effects of RNA polymerase inhibitors on nucleotidylylation of human norovirus VPg.

Antiviral research·2026
Same journal

Human monoclonal antibodies from donors vaccinated with recombinant vaccinia vaccine targeting A35 and B6 effectively inhibit orthopoxvirus spread and infection.

Antiviral research·2026
See all related articles

Hantaviruses, causing hantavirus pulmonary syndrome (HPS), gained attention as potential biological warfare (BW) agents. However, scientific understanding reveals hantaviruses lack ideal BW weapon characteristics.

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • Hantaviruses emerged in public awareness with hantavirus pulmonary syndrome (HPS) in the New World in 1993.
  • Initial speculation suggested hantaviruses as potential biological warfare (BW) agents due to their airborne nature and high fatality rate.
  • Hantavirus infections were already known in the Old World, presenting with varied and generally milder symptoms.

Purpose of the Study:

  • To evaluate the potential of hantaviruses as biological warfare (BW) agents.
  • To compare HPS in the New World with known hantavirus infections in the Old World.
  • To assess the characteristics of hantaviruses in the context of BW weapon suitability.

Main Methods:

  • Review of scientific literature on hantavirus epidemiology and clinical presentations.

Related Experiment Videos

  • Comparative analysis of hantavirus disease manifestations in the New and Old Worlds.
  • Assessment of hantavirus properties against criteria for biological warfare agents.

    • Main Results:

    • Hantavirus pulmonary syndrome (HPS) emerged rapidly with high mortality, fueling BW speculations.
    • Hantaviruses were largely unknown in the New World at the time of the HPS outbreak.
    • Despite initial concerns, hantaviruses possess limitations that make them unsuitable as ideal BW weapons.

    Conclusions:

    • Hantaviruses, while causing severe disease, do not meet the criteria for an effective biological warfare agent.
    • Understanding hantavirus epidemiology and characteristics is crucial for public health preparedness.
    • The initial BW concerns surrounding hantaviruses were largely unsubstantiated by scientific evidence.